Effects of systemic oxytocin and beta-3 receptor agonist (CL 316243) treatment on body weight and adiposity in male diet-induced obese rats.
Saved in:
| Title: | Effects of systemic oxytocin and beta-3 receptor agonist (CL 316243) treatment on body weight and adiposity in male diet-induced obese rats. |
|---|---|
| Authors: | Slattery JD; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Rambousek JR; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Tsui E; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Honeycutt MK; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Goldberg M; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Graham JL; Department of Nutrition, University of California, Davis, Davis, CA, United States., Wietecha TA; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington (UW) School of Medicine, Seattle, WA, United States.; University of Washington (UW) Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, WA, United States., Wolden-Hanson T; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., Williams AL; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States., O'Brien KD; University of Washington (UW) Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, WA, United States.; Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States., Havel PJ; Department of Nutrition, University of California, Davis, Davis, CA, United States.; Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States., Blevins JE; Veterans Affairs (VA) Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, United States.; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington (UW) School of Medicine, Seattle, WA, United States. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Mar 04; Vol. 16, pp. 1503096. Date of Electronic Publication: 2025 Mar 04 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2025.1503096 |
